PDEX

PDEX

PDEX

Letters With This Ticker

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Keywords/Themes	Theme Commentary	Pitches	Letter
2025 Q2	Aug 27, 2025	Long Cast Advisers	19.0%	-4.0%	CCRD, EEFT, MAMA, MTRX, PDEX, PESI, QRHC, RELL, RSSS	Cash, Demand Destruction, Microcaps, payments, small caps, Trade Policy, Valuations	Manager focuses on small company investing with concentrated positions in microcaps and small caps. Portfolio includes companies like CCRD, QRHC, MTRX, and RSSS with emphasis on finding undiscovered stocks trading at cheap valuations relative to expected growth and cash flow.	QRHC EEFT CCRD QRHC CCRD	View
2025 Q1	Jun 5, 2025	Long Cast Advisers	-20.0%	-20.0%	CCRD, GOOG, META, MTRX, PDEX, PESI, QRHC, RSSS	Concentration, Long Term, Outperformance, Price Discovery, small caps, value	Manager focuses exclusively on small company investing, seeking five-year doubles with 15% annualized returns. Portfolio concentrated in top-five positions representing 70% of holdings, with three stocks at or around 15% weightings.	PESI QRHC MTRX RSSS PDEX CCRD	View
2025 Q3	Nov 24, 2025	Long Cast Advisers	4.0%	-1.0%	MAMA, MTRX, PDEX, PESI, QRHC, RSSS	concentrated, healthcare, Manufacturing, Publishing, small caps, value	Fund focuses exclusively on small- and micro-cap companies that can grow over time, targeting 15% annualized returns. Manager emphasizes differentiated strategy versus indices which are overly represented by unprofitable, speculative companies. Portfolio concentrated in top five positions representing 60% of assets.	QRHC PESI RSSS MTRX PDEX	View
2023 Q3	Oct 31, 2023	Long Cast Advisers	6.0%	16.0%	AIM, CCRD, DAIO, MAMA, MTRX, PDEX, QHRC, RELL, RSSS, SANW, SNES, SOTK	Concentration, Manufacturing, Medical Devices, Quality, small caps, value	Manager focuses exclusively on small company investing with a research-intensive approach. Portfolio consists of small, customer-centric companies run by smart, humble managers who iterate towards better solutions. Small caps are currently discounted due to rising rates as they have more vulnerabilities than larger companies.	SOTK PDEX	View
2024 Q3	Oct 25, 2024	Long Cast Advisers	6.0%	16.0%	AAPL, BANC, CCRD, ENVX, GS, JPM, MTRX, PDEX, PESI, QRHC, SNES	Concentration, Medical Devices, payments, small caps, value	PDEX is a contract manufacturer to the medical device industry with a marquee torque limiting driver for orthopedic and maxillofacial surgeries. The company recently completed manufacturing expansion and now has capacity for $80M-$100M in sales, up from under $40M in FY21. Management is patient and thoughtful with a long-term approach.	CCRD PDEX	View
2025 Q4	Jan 24, 2026	Long Cast Advisers	1.0%	0.0%	CCRD, CCRN, EEFT, LSYN, MAMA, MTRX, NRC, PDEX, PESI, QRHC, RELL, RSSS	healthcare, Owner-Operator, small caps, Staffing, value	Significant focus on healthcare staffing through CCRN investment, with nurse staffing industry facing competitive pressures but potential for margin improvement. Also invested in NRC, a healthcare consulting and patient survey company with strong margins despite industry headwinds. Portfolio concentrated in small and micro-cap companies with intent to own for multiple years. Manager emphasizes patient capital approach targeting 15% annualized returns through well-researched small company investments. Focus on companies trading at attractive valuations with strong balance sheets and cash positions. CCRN example shows investment in company with 40% of market cap in cash and low enterprise value multiples.	RSSS MTRX NRC CCRN	View
2023 Q4	Feb 13, 2024	Long Cast Advisers	6.0%	16.0%	CCRD, DAIO, MAMA, MTRX, PDEX, QHRC, RELL, RSSS, SOTK	Concentration, Manufacturing, Medical Devices, small caps, value	PDEX operates as a contract manufacturer in the medical device space, producing battery-powered handheld drivers for surgeons. The company has doubled its manufacturing capacity and secured a large order doubling its backlog to $41M, suggesting strong growth potential for FY24.	SOTK PDEX	View
2024 Q4	Jan 24, 2025	Long Cast Advisers	20.0%	39.0%	CCRD, MTRX, PDEX, PESI, QRHC, RSSS	Concentration, Industrial, Microcap, Price Discovery, small caps, value	Manager focuses exclusively on small company investing, seeking five-year doubles with 15% annualized returns. Portfolio concentrated in top-five positions representing 70% of assets. Believes small cap managers handily beat relevant indices due to over-representation of unprofitable lottery tickets in benchmarks and sparse analyst coverage creating opportunities.	PESI QRHC MTRX RSSS PDEX CCRD	View

Pitches With This Ticker

Date	Pitch Type	Author	Company	Industry	Sub Industry	Bull / Bear	Stock Exchange	Keywords	Action
Apr 28, 2026	Fund Letters	Long Cast Advisers	Pro-Dex Inc	Health Care Equipment & Supplies	Health Care Equipment	Bull	NASDAQ	backlog growth, contract manufacturing, healthcare, insider ownership, Manufacturing Expansion, Medical Device, Oem, Surgical Instruments, Torque Limiting	View Pitch
Apr 28, 2026	Fund Letters	Long Cast Advisers	Pro-Dex Inc	Health Care Equipment & Supplies	Health Care Equipment	Bull	NASDAQ	backlog growth, contract manufacturing, healthcare, Manufacturing Expansion, Medical Device, small-cap, Surgical Instruments	View Pitch
Apr 13, 2026	Fund Letters	Long Cast Advisers	Pro-Dex Inc	Health Care	Health Care Equipment	Bull	NASDAQ	Branded Products, capacity expansion, Healthcare Equipment, manufacturing, Medical devices, Multi-year Contract, Surgical Instruments	View Pitch
Apr 13, 2026	Fund Letters	Long Cast Advisers	Pro-Dex Inc	Health Care Equipment & Services	Health Care Equipment	Bull	NASDAQ	capital-efficient, contract manufacturing, Healthcare Technology, Manufacturing Expansion, Medical Device, Orthopedic, Surgical Instruments	View Pitch
Apr 13, 2026	Fund Letters	Long Cast Advisers	Pro-Dex Inc	Health Care	Health Care Equipment	Bull	NASDAQ	Branded Products, Gross Profit, Healthcare Equipment, manufacturing, Medical devices, Multi-year Contract, Surgical Instruments	View Pitch
Jan 9, 2026	Seeking Alpha	Seeking Alpha	Pro-Dex, Inc.	Medical Devices	Orthopedic Devices	Bull	NASDAQ Stock Market	capital allocation, Customer concentration, financial health, growth potential, management success, operating margins, orthopedic devices, Pro-Dex, Inc., secular tailwinds, surgical drivers	View Pitch
Nov 28, 2025	Fund Letters	Avram Fisher	Pro-Dex, Inc.	Health Care	Medical Devices	Bull	NASDAQ	buybacks, Catalysts, EBITDA, Medtech, Oem, robotics, Smallcap, Surgical	View Pitch

BSD Shareholders of PDEX

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025

Manager Name	Fund Name	Fund AUM	Invested Value	Portfolio Weight	Shares Owned	Shares Bought / Sold During Quarter	% Bought / Sold During Quarter	% of Shares Outstanding Owned
No investor data available.

Join for free and get access to the buyside

Get insights from the world's most influential hedge fund investors direct to your inbox

Follow Us On: